JP Morgan Chase
THC icon

JP Morgan Chase’s Tenet Healthcare THC Stock Holding History

JP Morgan Chase’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Hold
7,200
– – ﹤0.01% 4472
2026
Q1 		$1.35M Sell
7,200
-93,800
-93% -$19.8M ﹤0.01% 4390
2025
Q4 		$20.1M Buy
101,000
+53,800
+114% +$10.9M ﹤0.01% 2067
2025
Q3 		$9.58M Buy
47,200
+7,200
+18% +$1.28M ﹤0.01% 2751
2025
Q2 		$7.04M Sell
40,000
-50,000
-56% -$7.53M ﹤0.01% 2851
2025
Q1 		$12.1M Hold
90,000
– – ﹤0.01% 2375
2024
Q4 		$11.4M Buy
90,000
+4,500
+5% +$669K ﹤0.01% 2576
2024
Q3 		$14.2M Buy
+85,500
New +$12.9M ﹤0.01% 2298
2022
Q1 		– Sell
-600
Closed -$49K – 7014
2021
Q4 		$49K Buy
+600
New +$43.9K ﹤0.01% 5958
2021
Q2 		– Sell
-5,800
Closed -$302K – 6609
2021
Q1 		$302K Sell
5,800
-148,100
-96% -$7.49M ﹤0.01% 4965
2020
Q4 		$6.14M Sell
153,900
-100
-0.1% -$3.23K ﹤0.01% 2626
2020
Q3 		$3.62M Sell
154,000
-141,600
-48% -$3.62M ﹤0.01% 2823
2020
Q2 		$5.35M Buy
295,600
+242,600
+458% +$4.78M ﹤0.01% 2404
2020
Q1 		$763K Sell
53,000
-137,000
-72% -$3.93M ﹤0.01% 3586
2019
Q4 		$7.23M Buy
190,000
+140,000
+280% +$4.19M ﹤0.01% 2392
2019
Q3 		$1.11M Buy
+50,000
New +$1.07M ﹤0.01% 3782
2018
Q1 		– Sell
-522,000
Closed -$7.91M – 5627
2017
Q4 		$7.91M Buy
522,000
+500,000
+2,273% +$7.04M ﹤0.01% 2309
2017
Q3 		$351K Buy
22,000
+8,000
+57% +$136K ﹤0.01% 3944
2017
Q2 		$271K Sell
14,000
-13,000
-48% -$227K ﹤0.01% 3911
2017
Q1 		$478K Buy
+27,000
New +$501K ﹤0.01% 3733
2016
Q3 		– Sell
-414,000
Closed -$11.4M – 4798
2016
Q2 		$11.4M Sell
414,000
-1,986,000
-83% -$58.7M ﹤0.01% 1749
2016
Q1 		$69.4M Buy
2,400,000
+2,380,000
+11,900% +$61.9M 0.02% 672
2015
Q4 		$606K Buy
+20,000
New +$656K ﹤0.01% 3321

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

JP Morgan Chase's THC Position: Q2 2026 in Review

JP Morgan Chase increased its Tenet Healthcare (THC) stake by 37% in Q2 2026, buying an estimated $19.9M and bringing the position to 403,961 shares worth $76.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1204.

JP Morgan Chase first reported a position in THC in Q2 2013 and has held it in 53 quarters since. The position peaked at $97.7M in Q4 2019. 680 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • JP Morgan Chase held 403,961 shares of Tenet Healthcare worth $76.4M as of Q2 2026.
  • JP Morgan Chase bought 108,047 Tenet Healthcare shares in Q2 2026, an estimated $19.9M.
  • Tenet Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1204 holding.
  • JP Morgan Chase first reported a position in Tenet Healthcare in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Tenet Healthcare position peaked at $97.7M in Q4 2019.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.